Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

Semaglutide Dosage & Reconstitution

GLP-1 receptor agonist. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: clinical.

1Set Up Your Mix

5 mg/mL · 5000 mcg/mL

Your Answer — Semaglutide

10 mg in 2 mL
5Draw To This Line
0.05That's This Many mL
40Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 5
10 mg ÷ 2 mL = 5 mg/mL  →  0.25 mg ÷ 5 mg/mL = 0.05 mL  →  × 100 = 5 units
Looks good. Draw to 5 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 40 doses.
When to dose
Time of dayAny time of day. Weekly compounds should be kept to the same day each week.
FoodWith or without food — it makes no meaningful difference.

These are long-acting and reach steady state over weeks, so a single day’s timing has little effect. Consistency matters more than the hour.

2Week-By-Week Plan — Semaglutide

Approved-label escalation
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Weeks 1–4 0.25 mg once weekly 0.05 mL 5 u 4 1 mg
Weeks 5–8 0.5 mg once weekly 0.1 mL 10 u 4 2 mg
Weeks 9–12 1 mg once weekly 0.2 mL 20 u 4 4 mg
Weeks 13–16 1.7 mg once weekly 0.34 mL 34 u 4 6.8 mg
Week 17 onward
per 4 weeks from here on
2.4 mg once weekly 0.48 mL 48 u 4 9.6 mg
Time until the top dose
16 weeks
Peptide used getting there
13.8 mg
Vials you'll need
2 × 10 mg
Once you're at the top dose
9.6 mg / 4 wk · 0.96 vials
Where this plan came from
A published dosing schedule
Where this came from: STEP 1 trial protocol and the approved 2.4 mg escalation schedule. Steps exist to manage gastrointestinal tolerability. Trial protocols hold or step back down when a dose is not tolerated rather than pushing forward on schedule.

3Common Doses — Semaglutide

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Initiation (wk 1–4) 0.25 mg once weekly 0.05 mL 5 u 40 doses
Escalation (wk 5–8) 0.5 mg once weekly 0.1 mL 10 u 20 doses
Escalation (wk 9–12) 1 mg once weekly 0.2 mL 20 u 10 doses
Escalation (wk 13–16) 1.7 mg once weekly 0.34 mL 34 u 5 doses
Trial maintenance 2.4 mg once weekly 0.48 mL 48 u 4 doses
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About Semaglutide

Metabolic / Incretin
Also known as
GLP-1 receptor agonist
Class
Metabolic / Incretin
Route
Subcutaneous
Half-life
~7 days
Evidence tier
Clinical

The most extensively trialled compound in this database. Approved formulations follow a fixed escalation schedule to manage gastrointestinal tolerability; the figures below reflect the STEP obesity trial titration.

Buy Semaglutide

Common Questions — Semaglutide

How much bacteriostatic water do I add to a 10 mg vial of Semaglutide?

Adding 2 mL of bacteriostatic water to a 10 mg vial gives 5 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.

What dose of Semaglutide is used in research?

Published and reported figures for Semaglutide run from 0.25 mg to 2.4 mg, typically once weekly.25 mg to 2.4 mg, typically once weekly.25 mg to 2.4 mg, typically once weekly. This site lists each figure with the source it came from rather than giving a single recommended number.

How many units on the syringe is a 0.25 mg dose of Semaglutide?

At 5 mg/mL, a 0.25 mg dose is 5 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 40 doses.

How strong is the evidence behind these Semaglutide doses?

Semaglutide is graded clinical. Human trial or approved-label dosing has been published for this compound. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.

Is there a Semaglutide titration schedule?

Yes — Approved-label escalation. The week-by-week table on this page converts each step into the exact amount to draw for your mix.

Where These Numbers Come From

Clinical — Human trial or approved-label dosing published
Once-weekly semaglutide in adults with overweight or obesity (STEP 1) Wilding JPH, et al. New England Journal of Medicine, 2021
The pivotal 68-week obesity trial; source of the 2.4 mg maintenance dose and the escalation schedule.
Find on PubMed ↗
Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT) Lincoff AM, et al. New England Journal of Medicine, 2023
Large cardiovascular outcomes trial; the strongest safety dataset at the 2.4 mg dose.
Find on PubMed ↗
Semaglutide 2.4 mg — pharmacokinetics and dose-response Overgaard RV, et al. Clinical Pharmacokinetics, 2021
Underpins the weekly cadence and the ~1-week half-life figure.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Need this on one page to print, screenshot or send?

Make a dose card →

Other metabolic / incretin peptides

Compounds in the same class, or browse the full catalogue.

5-Amino-1MQ

A small-molecule NNMT inhibitor rather than a true peptide. Research data show reduced adiposity in diet-induced obesity models. D…

All 72 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.